Literature DB >> 6712205

Biological action of inosine analogs in Leishmania and Trypanosoma spp.

J J Marr, R L Berens, N K Cohn, D J Nelson, R S Klein.   

Abstract

Previous investigations have suggested that inosine analogs would be good models for the development of chemotherapeutic agents active against pathogenic hemoflagellates. We have systematically modified the five-membered heterocyclic ring of six inosine analogs and tested them for their antiprotozoal activities and toxicity to a mammalian cell line. All six analogs were very active against the three protozoan pathogens Leishmania donovani, Trypanosoma cruzi, and Trypanosoma gambiense. Two of the six, 9-deazainosine and allopurinol ribonucleoside, had very little toxicity for mouse L cells and offer promise as potential chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712205      PMCID: PMC185495          DOI: 10.1128/AAC.25.2.292

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Studies on formycin and formycin B in cells of Ehrlich carcinoma and E. coli.

Authors:  H Umezawa; T Sawa; Y Fukagawa; I Homma; M Ishizuka
Journal:  J Antibiot (Tokyo)       Date:  1967-11       Impact factor: 2.649

2.  Purine nucleoside phosphorylase from human erythrocytes. 3. Inhibition by the inosine analog formycin B of the isolated enzyme and of nucleoside metabolism in intact erythrocytes and sarcoma 180 cells.

Authors:  M R Sheen; B K Kim; R E Parks
Journal:  Mol Pharmacol       Date:  1968-05       Impact factor: 4.436

3.  Stereochemical analysis of the specificity of pancreatic RNAse with polyformycin as substrate: differentiation of the transphosphorylation and hydrolysis reactions.

Authors:  D C Ward; W Fuller; E Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

4.  Ribonucleosides of allopurinol and oxoallopurinol. Isolation from human urine, enzymatic synthesis, and characterization.

Authors:  T A Krenitsky; G B Elion; R A Strelitz; G H Hitchings
Journal:  J Biol Chem       Date:  1967-06-10       Impact factor: 5.157

5.  Influence of formycin B on polyadenosine diphosphoribose synthesis in vitro and in vivo.

Authors:  W E Müller; H J Rohde; R Steffen; A Maidhof; M Lachmann; R K Zahn; H Umezawa
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

6.  Antileishmanial effect of allopurinol. II. Relationship of adenine metabolism in Leishmania species to the action of allopurinol.

Authors:  J J Marr; R L Berens
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

7.  Antiviral effect of formycin and formycin B.

Authors:  T Takeuchi; J Iwanaga; T Aoyagi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1966-11       Impact factor: 2.649

8.  Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.

Authors:  G B Elion; A Kovensky; G H Hitchings
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

9.  Antileishmanial effect of allopurinol.

Authors:  M A Pfaller; J J Marr
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

10.  Formation of nucleotides of (6-14C)allopurinol and (6-14C)oxipurinol in rat tissues and effects on uridine nucleotide pools.

Authors:  D J Nelson; C J Buggé; H C Krasny; G B Elion
Journal:  Biochem Pharmacol       Date:  1973-08-15       Impact factor: 5.858

View more
  14 in total

1.  Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis.

Authors:  C J Bacchi; R L Berens; H C Nathan; R S Klein; I A Elegbe; K V Rao; P P McCann; J J Marr
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines.

Authors:  Kartik W Temburnikar; Christina R Ross; Gerald M Wilson; Jan Balzarini; Brian M Cawrse; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2015-06-16       Impact factor: 3.641

3.  Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.

Authors:  Mohammed I Al-Salabi; Harry P de Koning
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  3'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo.

Authors:  I S Shin; H Tanifuji; Y Arata; Y Morizawa; T Nakayama; Y Wataya
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

5.  Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.

Authors:  M Chen; S B Christensen; J Blom; E Lemmich; L Nadelmann; K Fich; T G Theander; A Kharazmi
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

6.  Activity of purine analogs against Leishmania donovani in vivo.

Authors:  J D Berman; W L Hanson; J K Lovelace; V B Waits; J E Jackson; W L Chapman; R S Klein
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

7.  5-Substituted pyrimidine acyclic nucleoside analogues 1-cyanomethyl- and 1-(4-cyanobutyl)-5-substituted uracils as candidate antitumor agents.

Authors:  J C Kim; E S Dong; J I Park; S D Bae; S H Kim
Journal:  Arch Pharm Res       Date:  1994-12       Impact factor: 4.946

8.  Inosine analogs as chemotherapeutic agents for African trypanosomes: metabolism in trypanosomes and efficacy in tissue culture.

Authors:  W R Fish; J J Marr; R L Berens; D L Looker; D J Nelson; S W LaFon; A E Balber
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

9.  In vitro and in vivo activities of formycin B against Trypanosoma cruzi.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Activity of inosine analogs against Pneumocystis carinii in culture.

Authors:  M S Bartlett; J J Marr; S F Queener; R S Klein; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.